Does smoking cessation with varenicline worsen vascular endothelial function?

OBJECTIVES: A meta-analysis suggested that the use of varenicline, which is a partial agonist of nicotinic acetylcholine receptors and is effective in smoking cessation, increases the risk of cardiovascular events within 52 weeks of starting treatment. Defining these events as occurring during drug...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Umeda, Akira, Kato, Toru, Yamane, Tateki, Yano, Heiichi, Ieiri, Tamio, Miyagawa, Kazuya, Takeda, Hiroshi, Okada, Yasumasa
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2013
Предметы:
Smoking and Tobacco
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://ncbi.nlm.nih.gov/pubmed/23794597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003052
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы